Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas

BackgroundMaximum safe resection followed by chemoradiotherapy as current standard of care for WHO grade III and IV gliomas can be influenced by the occurrence of perioperative adverse events (AE). The aim of this study was to determine the association of AE with the timing and choice of subsequent...

Full description

Bibliographic Details
Main Authors: Lorenz Weber, Luis Padevit, Timothy Müller, Julia Velz, Flavio Vasella, Stefanos Voglis, Dorothee Gramatzki, Michael Weller, Luca Regli, Johannes Sarnthein, Marian Christoph Neidert
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
adverse events
complications
glioblastoma
treatment delay
subsequent therapy
high grade glioma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.959072/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.959072/full

Similar Items